GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Clinomics Inc (XKRX:352770) » Definitions » Other Income (Expense)

Clinomics (XKRX:352770) Other Income (Expense) : ₩-2,838 Mil (TTM As of Mar. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Clinomics Other Income (Expense)?

Clinomics's other income expense for the Clinomics's pretax income for the three months ended in Mar. 2024 was ₩418 Mil. Its other income expense for the trailing twelve months (TTM) ended in Mar. 2024 was ₩-2,838 Mil.


Clinomics Other Income (Expense) Historical Data

The historical data trend for Clinomics's Other Income (Expense) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Clinomics Other Income (Expense) Chart

Clinomics Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Income (Expense)
Get a 7-Day Free Trial 66.10 125.69 2,717.39 3,113.51 -3,431.99

Clinomics Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Other Income (Expense) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -175.99 -427.50 -455.35 -2,373.15 418.00

Clinomics Other Income (Expense) Calculation

Other income expense includes minority interest. Minority interest is a significant but non-controlling ownership of less than 50% of a company's voting shares by either an investor or another company.

Other Income (Expense) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-2,838 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Clinomics  (XKRX:352770) Other Income (Expense) Explanation

Minority interest is reported on the consolidated income statement as a share of profit belonging to minority shareholders.


Clinomics (XKRX:352770) Business Description

Traded in Other Exchanges
N/A
Address
50 Unist-Gil, Eonyang-eup, Ulju-gun, Ulsan, KOR, 44919
Clinomics Inc is a biotechnology company. The company provides early diagnosis of cancer/diseases based on genome and pursues to overcome aging and diseases through liquid biopsy and Multi-Omics technology.

Clinomics (XKRX:352770) Headlines

No Headlines